WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth

As on 23 Apr 2025

logo

WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth

Equity

NAV

13.28

CAGR (3 Years)

%

AUM (Cr)

303.62

Risk

Very High Risk

About WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. However, there can be no assurance that the investment objective of the Scheme will be realized.

Breakdown of this Fund

logo
Chemicals
3.33%
logo
Debt Others
8.73%
logo
Healthcare
48.63%
logo
IT - Software
0.55%
logo
Pharmaceuticals
93.92%
logo
Plastic products
1.35%
logo
T Bills
5.74%

Market Capitalization

Get your FAQs right

What kind of returns does WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth provide?

plus

How much expense ratio is charged by WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth?

plus

What is the AUM of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth?

plus

What is the NAV of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth?

plus

What is the PE and PB ratio of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth?

plus

What is the exit load of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth?

plus

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions